1Apeldoom AT, Bosmans JE, Ostelo RW, et al. Cost-effectiveness of a classification-based system for sub- acute and chronic low back pain. Eur Spine J, 2012, 21(7):1290-300.
2Lin C WC, Haas M, Maher C G, et al. Cost-effectiveness of guideline-endorsed treatments for low back pain: a systematic review. Eur Spine J, 2011, 20(7):1024-1038.
3Ohtori S, Inoue G, Orita S, et al. Transdermal fentanyl for chronic low hack pain. Yonsei Med J, 2012, 53(4):788-793.
4Oksuz E. Prevalence, risk factors, and preference-based health states of low back pain in a Turkish population. Spine, 2006, 31(25):E968-E972.
5Ciapetti G, Granchi D, Devescovi V, et al. Ex vivo observation of human intervertebral disc tissue and cells isolated from degenerated intervertebral discs. Eur Spine J, 2012, 21(1):10-19.
6Park MS, Lee HM, Hahn S B, et al. The association of the activation- inducible tumor necrosis factor receptor and ligand with lumbar disc herniation. Yonsei Med J, 2007, 48(5):839-846.
7Roberts S. Disc morphology in health and disease. Biochem Soc Trans. 2002. 30(Pt 6):864-869.
